Uncontrolled secretion of mature interleukin (IL)-1β and IL-18 is responsible for severe autoinflammatory or autoimmune disorders and various allergic diseases. Here we report an intramolecular interaction between IL-18 and its propeptide, which is proteolytically removed from its precursor proIL-18 during maturation. The intramolecular interaction was recapitulated intermolecularly using recombinant propeptide. These results suggest the possibility of developing a novel class of peptide-based IL-18 inhibitors that could serve as therapeutic agents for IL-18-related inflammatory diseases.
(NLRP3) 10 induce uncontrolled NLRP3 inflammasome activation, which eventually leads to chronic inflammation because of IL-1β hyper-production. Similarly, certain mutations in the NLR family CARD domain-containing protein 4 (NLRC4) evoke periodic fevers of lethal macrophage-activating syndrome (MAS) [11] [12] [13] , in which patients suffer from extremely high blood levels of IL-18 in addition to elevated levels of IL-1β. Interestingly, IL-18 levels in NLRC4-MAS patients remain high for a long period, even after IL-1β blockade. These findings reinforce the concept that PPs as important regulators of proinflammatory IL-1β and IL-18.
In addition to NLRC4-MAS, IL-18 is associated with various severe chronic inflammatory diseases such as CAPS, familial Mediterranean fever, adult-onset Still's disease (AOSD), pyogenic arthritis, pyoderma gangrenosum, acne syndrome, and systemic juvenile idiopathic arthritis with MAS [18] [19] [20] [21] [22] . High blood concentrations of IL-18 are also found in patients with allergic diseases, including bronchial asthma, atopic dermatitis, inflammatory bowel disease, and the X-linked inhibitor of apoptosis (XIAP) deficiency [23] [24] [25] [26] . Genetic polymorphisms have also been reported in the IL-18 or IL-18 receptor genes of patients with autoimmune diseases, allergic reactions, and neurological/metabolic syndromes [27] [28] [29] [30] [31] . Neutralizing IL-1β by using either anti-IL-1β antibodies (Canakinumab) or engineered soluble receptors (Rilonacept), or by antagonizing the receptor with IL-1Ra (Anakinra), treat IL-1β-related autoinflammatory diseases effectively [32] [33] [34] [35] . Similarly, anti-IL-18 antibodies inhibit the development of atopic dermatitis and asthma-like phenotypes in mouse models 36, 37 . A recombinant human IL-18-binding protein (IL-18BP, Tadekinig Alfa), an endogenous antagonist of IL-18, is also in mid-late phase clinical trials for AOSD, XIAP deficiency and NLRC4-MAS [38] [39] [40] . Here, we demonstrate an intramolecular interaction between the mature region of IL-18 and its PP, providing a solid framework for further investigations of PPs' roles in IL-1F ligands' molecular function. These results also suggest the possibility of developing a new class of peptide-based drugs to treat IL-1F-associated inflammatory diseases.
Methods
Construction of expression vectors. The coding region of the full-length human IL-18 precursor (proIL-18, NM_001562.3, residues 1-193) was amplified from a human cDNA library by a polymerase chain reaction and cloned into a pET-28a vector (Novagen, WI, USA), which was engineered to contain a 6× His-tagged N-terminal small ubiquitin-like modifier (SUMO)-3 (NM_006936.2, residues 14-92) for protein expression and purification. The plasmids for mature IL-18 (residues 37-193) and proIL-18PP (residues 1-36) were derived from the proIL-18 construct by deleting residues 1-36, or by replacing Y37 with a stop codon, respectively, using a KOD -Plus-Mutagenesis kit (Toyobo, Osaka, Japan). The constructs for the N-terminal-truncated proIL-18 variants (proIL-18ΔNs), namely, proIL-18Δ8N (residues 9-193), proIL-18Δ10N (residues 11-193), proIL-18Δ12N (residues , proIL-18Δ13N (residues ) and proIL-18Δ22N (residues , were prepared in the same manner as the IL-18 expression plasmid.
Protein expression and purification. The expression vectors for proIL-18, proIL-18ΔNs, IL-18 and proIL-18PP were transformed into E. coli BL21(DE3) cells, and the bacteria were grown in LB medium or M9 minimal media containing either 15 O 6 at 37 °C in the presence of 25 μg/ mL kanamycin. Cultures were cooled on ice to 18 °C when the optical density at 600 nm reached 1.0, and protein expression was induced by adding 1.0 mM IPTG. Cells were harvested after incubating for 16 h at 18 °C, resuspended at 4 °C in lysis buffer (20 mM Tris.HCl, pH 8.0, 150 mM NaCl, 20 mM imidazole and 0.5-2 mM DTT), and supplemented with 1 mM PMSF for proIL-18, proIL-18ΔNs and IL-18 or with cOmplete EDTA-free Protease Inhibitor Cocktail (Roche Applied Science, Penzberg, Germany) for proIL-18PP. After sonication on ice and centrifugation, the supernatant was applied to an Ni affinity column (cOmplete His-Tag Purification Resin, Roche Applied Science) equilibrated with lysis buffer. After washing with lysis buffer, followed by detergent buffer (20 mM Tris.HCl, pH 8.0, 150 mM NaCl, 20 mM imidazole, 1% Triton X-100 and 2 mM DTT), high-salt buffer (20 mM Tris.HCl, pH 8.0, 1 M NaCl, 20 mM imidazole and 2 mM DTT) and then again with lysis buffer, the His-SUMO tag was removed by digestion with a homemade SUMO-specific protease GST-SENP2 for 16 h at 4 °C on column. The protein solution was eluted and allowed to flow through a glutathione sepharose (GE Healthcare, Little Chalfont, UK) to remove the protease. The flow through was further purified using a HiTrap Q anion exchange column (GE Healthcare) and eluted with an NaCl gradient from 50 mM to 500 mM. This was followed by a size-exclusion chromatography on a HiLoad 16/60 Superdex 75 column (GE Healthcare). The gel-filtration column was equilibrated with either NMR buffer (20 mM potassium phosphate, pH 6.0, 150 mM KCl and 1 mM TCEP) for proIL-18, proIL-18ΔNs and IL-18 or with 300 mM ammonium acetate for proIL-18PP. The proIL-18PP eluate was quantitated, aliquoted and lyophilized.
NMR spectroscopy. NMR spectra were measured on Bruker Avance II 700 MHz, Avance 600 MHz and Avance III 500 MHz spectrometers equipped with cryogenic probes. The samples for NMR analyses were dissolved in either NMR buffer or caspase-1 reaction buffer (20 mM HEPES-Na pH 7.4, 100 mM NaCl, 1 mM EDTA and 10 mM DTT), which was exchanged by dialysis, and 5 v/v % D 2 Circular dichroism (CD) spectroscopy. CD spectra were collected on a J-700 spectrophotometer (JASCO, MD, USA) from 250 to 200 nm at 0.1 nm intervals. The proIL-18 and IL-18 concentrations were adjusted to 0.2 mg/mL in NMR buffer and data were reported as molar ellipticity θ (deg cm 2 /dmol). For thermal studies, the molar ellipticity at 215 nm were recorded from 20 °C to 80 °C at a heating rate of 1 °C/min, with 0.2 °C intervals. Data were processed using Igor Pro 6.2.2.0 (WaveMetrics, OR, USA) using moving averages of 1 nm and 1 °C for the comparison of spectral pattern and thermal scanning, respectively.
Results
Detection of the interaction between IL-18 and proIL-18PP. We first prepared mature IL-18 and proIL-18, the precursor of IL-18, for analysis by NMR spectroscopy. All recombinant IL-18 variants were expressed with an N-terminal SUMO tag to precisely produce the polypeptide sequences of interest; an analogous method has been reported to produce fully bioactive IL-18 44 . The 2D 1 H-15 N HMQC spectrum of [ 15 N]-IL-18 prepared in this way was essentially identical to the one we obtained in our previous structural studies of IL-18 9, 45 , indicating that the sample protein had the proper tertiary structure to form the signaling ternary complex. ProIL-18 exhibited a monomeric, mono-disperse nature upon size-exclusion chromatography, as did IL-18 ( Supplementary Fig. 1a and ref. 46 Fig. 1a and ref. 9 ), suggesting that the PP (Fig. 1b right, residues 1-36) makes extensive contact with the mature region ( Fig. 1b right, residues and/or prevents the proper folding of the mature region via certain intramolecular interactions. The cross-peaks were substantially broadened, likely reflecting relatively weak interactions and low structural homogeneity of the molecule. In terms of function, the The cross-peak intensities decreased remarkably in the presence of IL-18 for amino acid residues from Asn9 to Ala27 (pink). Reliable peak intensities were not obtained for residues with gray backgrounds because of peak overlap.
www.nature.com/scientificreports www.nature.com/scientificreports/ distinct structural state of proIL-18, revealed by the NMR spectra, is consistent with its inability to activate IL-18 receptors, triggering IL-18 signaling 47, 48 . Since the receptors recognize large surface areas of IL-18 9 , the clearly distinct structure of proIL-18 should hamper binding.
To determine whether the observed intramolecular interaction can be reproduced intermolecularly, we next examined the binding between a peptide comprising the PP sequence (proIL-18PP, Supplementary Fig. 1b Fig. 2b ), confirming that there is essentially no secondary structure in the free peptide.
However, the NMR spectrum of [
15 N]-proIL-18PP changed substantially in the presence of three molar equivalents of IL-18, with new cross-peaks appearing at a δ( 1 H) of 9.5-8.5 ppm, indicating specific interaction between proIL-18PP and IL-18 and the formation of an ordered structure in the peptide (Fig. 1c) . These new peaks can be superimposed on certain peaks of [
15 N]-proIL-18 (Fig. 2a, top left) , suggesting that the peptide experiences the same environment as proIL-18. In other words, proIL-18PP's binding to IL-18, at least partly, recapitulates the native intramolecular interactions within proIL-18. Although we were unable to assign the new cross-peaks, a certain portion of proIL-18PP was thought to form a β-strand structure based on the amide 1 H chemical shifts of the peaks (Supplementary Fig. 2c ). This interpretation agrees with secondary structure prediction, where Cys10-Ile19 and Thr22-Ala27 adopt short β-strand configurations (Supplementary Fig. 2d) . Intriguingly, 1 H-15 N NMR signals from amino acids residues in the predicted β-strands were substantially broadened during the titration (Fig. 1d ).
Based on the ]-proIL-18PP in the presence of three molar equivalents of IL-18, the dissociation constant (K D ) of the interaction was evaluated as >36 μM. This affinity is in the moderate range, however, in full-length proIL-18, these two regions are connected into a single molecule by a peptide bond, so that they should assemble more tightly. As shown in Fig. 1d , when three molar equivalents of IL-18 were present, the cross-peak intensities of free [
15 N]-proIL-18PP decreased, which was substantial for amino acid residues from Asn9 to Ala27. This observation suggests this region that mainly interacts with IL-18, while the remainder of the peptide does not.
To further explore the region in the PP sequence that is essential for IL-18 binding, we next recorded the 1 H- 15 N HMQC spectra of a series of N-terminally truncated proIL-18 derivatives (proIL-18ΔNs) and compared them to full-length proIL-18 and mature IL-18 (Fig. 2) . [ www.nature.com/scientificreports www.nature.com/scientificreports/ Because the spectral comparison did not reveal any obvious differences in the locations of the well-isolated cross-peaks, the first eight amino acid residues of proIL-18 may adopt a random coil whose cross-peaks are presumably buried in the crowded and indistinguishable region at approximately a δ( 1 H) of 8.4-8.0 ppm. Additional derivatives were also tested; intriguingly, after deleting the first ten residues of proIL-18 (proIL-18Δ10N, Fig. 2 right), the spectra was broadened substantially, presumably because of intermediate states between proIL-18 and IL-18. Furthermore, the reference cross-peak of full-length proIL-18 began to change (squared peak in Fig. 2 ). In addition, deletion of the first 12 residues (proIL-18Δ12N, Fig. 2 bottom left) completely altered the spectrum to resemble the mature protein, indicating a critical importance of residues near Ile11. Further deletion did not produce major spectral changes, and proIL-18Δ13N and proIL-18Δ22N yielded essentially the same spectra as proIL-18Δ12N (Supplementary Fig. 3 ). Taken together, these data suggest that residues 9-11 play a central role in the interaction, although residues 12-27 probably also participate in IL-18 binding.
In cells, proIL-18 maturation occurs via cleavage by caspase-1. To obtain insights into this reaction, we performed in situ NMR analysis of the maturation reaction in a test tube, wherein 1 H-15 N HMQC spectra of [
15 N]-proIL-18 were sequentially recorded in the presence of active caspase-1 (Fig. 3a-c and Supplementary  Fig. 4a ). The majority of [ 15 N]-proIL-18 was digested within one hour and the reaction was complete after 24 hours, according to SDS-PAGE analysis (Fig. 3a) . However, even in the NMR spectrum recorded 24 hours after the addition of caspase-1, essentially all cross-peaks for [ 15 N]-proIL-18 remained, although their intensity had decreased by approximately 50% (Fig. 3b,c) . In addition, new cross-peaks corresponding to mature IL-18 were apparent, indicating that some fraction of proIL-18 was structurally converted to the mature form (Fig. 3d) . These observations indicate that ~50% of the generated proIL-18PP was still in complexed with the mature region, even after cleavage by caspase-1. In fact, considering the initial concentration of proIL-18 in this experiment (200 μM), the K D can be estimated from the NMR spectra (Fig. 3b) as approximately 100 μM, similar to the value determined by titration (Fig. 1c) . To confirm the spectral pattern of the mature region of IL-18 in the peptide-bound state, we measured www.nature.com/scientificreports www.nature.com/scientificreports/ non-label proIL-18PP. The yielded spectrum had the similar features to proIL-18, as was in the caspse-1 cleaved experiment but with no signal from free and complexed proIL-18PP (Fig. 3e and Supplementary Fig. 4b ).
ProIL-18 is more stable than mature IL-18. To compare the secondary structures and folding properties of proIL-18 and IL-18, we collected circular dichroism (CD) spectra in NMR buffer containing 150 mM NaCl (Fig. 4) . Consistent with the reported β-trefoil structure 9, 45 with abundant β-hairpins and short connecting loops, IL-18 produced a broad, negative peak at 208 nm (Fig. 4a, red) with a spectral pattern very similar to the reported CD spectra of IL-1Ra and IL-36γ 50, 51 . The negative band of proIL-18 was broadened and shifted to a lower wavelength relative to IL-18 (Fig. 4a, blue) , indicating a slightly higher random coil content in proIL-18. We then performed thermal scanning by recording CD values at 215 nm 50 from 20 °C to 80 °C at a heating rate of 1 °C/ min (Fig. 4b) . IL-18 denatured at a melting temperature (T m ) of 55 °C, while the CD value of proIL-18 remained unchanged at this point. The CD value of proIL-18 began to drop near 58 °C did so gradually to approximately 68 °C, where it became stable. This decrease in the CD value can be attributed to soluble aggregation 52 and the midpoint of the transition between the two states was 63 °C.
The same trend was observed in the high-temperature NMR experiments (Fig. 5a,b) . IL-18 formed an irreversible white precipitate at 50 °C after the course of 73 min of measurement, and all cross-peaks disappeared from the spectrum. In contrast, the spectral pattern of proIL-18 was essentially the same between 40 °C and 50 °C, and the signal intensity only decreased by 30% (Fig. 5c ). The T m was higher than 50 °C for IL-18 in the temperature scan with the CD measurement (Fig. 4b) , whereas the protein precipitated at 50 °C in the NMR study. The discrepancy between these two experiments could be attributable to the difference in the experimental time scales; the temperature in the CD measurements was too fast to allow establishment of a thermal equilibrium state at each temperature. Nevertheless, in both cases, proIL-18 exhibited higher thermostability than IL-18, marking a sharp contrast to proIL-1β, which is substantially less stable than its mature form 53 .
Discussion
Previous structural studies have revealed that mature IL-18's N-terminal tyrosine residue is relatively proximal, in the binary complex, to the glycan chain on Asn297 of the primary receptor IL-18Rα 9, 54 . Hence, it was likely that the 36-amino acid PP of proIL-18 would sterically hinder binding and so the formation of the signaling complex. In this study, we provided a more detailed structural view of proIL-18 by demonstrating that the PP region extensively interacts with the mature region of proIL-18. Chemical shifts of amide 1 H suggest that at least a part of the PP region likely adopts a β-strand configuration in proIL-18, implying β-sheet formation between the PP and mature regions. Nevertheless, the resemblance of the CD spectra indicated similar secondary structure content between proIL-18 and IL-18 except for random coils. Thus, a part of the mature region's β-trefoil structure might have been distorted in proIL-18. The extensively interacting PP region may add additional complexity to determining IL-18's bioactivities. Due to its potent proinflammatory activity, the IL-18 activity must be tightly regulated. In fact, under normal conditions, blood IL-18 is bound to natural inhibitors, the IL-18 binding protein (IL-18BP) 30 and soluble IL-18Rs (sIL-18Rα and sIL-18Rβ) 55 , which neutralize its activity. However, in some detrimental autoimmunity or autoinflammatory conditions [18] [19] [20] [21] [22] [23] [24] [25] [26] , systemic IL-18 levels are elevated and far exceed those of their antagonists, resulting in the appearance of the active cytokine. Similar tight regulation has also been observed in the IL-1β system, where soluble IL-1 receptors (sIL-1RI and sIL-1RII), a decoy cell-surface receptor (IL-1RII) and an IL-1 receptor antagonist (IL-1Ra) play anti-inflammatory roles in vivo. Previous structural characterization of proIL-1β suggested that its PP region prevents the completion of β-trefoil barrel folding by directly interfering with the mature region, although the PP largely adopts a random coil conformation 53 , and thus binding of immature IL-1β to its specific receptors is abrogated. Therefore, PP regions might share a common mechanism for securely suppressing IL-1β/IL-18's proinflammatory activities.
An intriguing difference between proIL-18 and proIL-1β concerns their folding stability. Our CD and NMR studies have revealed that proIL-18 has an enhanced thermostability relative to the mature protein, which may be advantageous in preserving the precursor in the cytosol for longer durations. This is in sharp contrast to proIL-1β, whose PP in the immature form has been proposed to prevent full barrel formation of the mature region, destabilizing the protein 53 . This difference distinguishes two closely related members of IL-1F, in which IL-18 mRNA www.nature.com/scientificreports www.nature.com/scientificreports/ and protein are constitutively expressed and stored in the cytosol, whereas IL-1β is transcribed and produced on-demand by various stimuli, such as lipopolysaccharides, and processed to the mature form immediately 56 . IL-1β's instability may be related to its secretion pathway, where an unconventional autophagy-mediated mechanism has been proposed to be responsible for IL-1β release. In this pathway, less stable proIL-1β is more susceptible to protease-dependent degradation and is, thus, prevented from being secreted 6 . ProIL-18's higher stability implies that a similar pathway is not used for IL-18 secretion.
The present NMR study demonstrates that proIL-18PP binds to IL-18 to produce dramatic spectral changes in IL-18 (Figs 1-3 ) that are comparably extensive to those observed when [ 15 N]-IL-18 binds the extracellular region of IL-18Rα 9 . Because IL-18BP, a potent IL-18 inhibitor, only mimics one of the three subdomains of IL-18Rα when binding IL-18, it is possible that proIL-18PP interferes with the binding between IL-18 and IL-18Rα. However, the intermolecular binding between proIL-18PP and IL-18 has a lower affinity (tens to 100 μM) than the intramolecular binding between the pro and mature region of proIL-18 because there was no peptide bond between them. Thus, their interaction should be short-lived. Furthermore, peptides are generally susceptible to protease digestion in cell culture and in vivo. Hence, proIL-18PP's inhibitory effect on IL-18 activities may not be very strong. Nevertheless, optimizing its binding properties by changing its amino acid sequence or reformatting it into peptibodies 57 containing multiple proIL-18PP-like sequences may produce more potent inhibitory compounds. Because proIL-18PP is an endogenous polypeptide generated from proIL-18 upon maturation, its immunogenicity and toxicity should be low if such modifications were minimal; this would be highly beneficial for clinical application, and so proIL-18PP may represent an excellent seed compound to develop IL-18-neutralizing drugs in the future. In this context, our extensive NMR analysis has provided valuable information, i.e., that the central three amino acid residues in proIL-18PP play a key role in mediating its interaction with mature IL-18.
IL-18's natural inhibitory mechanism could be applied to other IL-1F ligands, which will affect our understanding of IL-1F biology and the development of therapeutics for IL-1F-related diseases.
Data Availability
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